Preparation of indapamide slow-release pellets

Wei Jia, Mingfeng Qiu, Xia Sun, Yunping Qiu, Mingming Su

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

During the process of developing a slow-release formulation of indapamide, researchers created a drug-containing pellet coated with Eudragit® RS100 (Rohm GMbH & Co. KG, Darmstadt, Germany) to control the rate at which the drug was released. The two main variables were the agglomerants used in the pellet preparation and the amount of Eudragit RS100 used to coat them. The optimal outcome was indicated by the greatest number of drug-containing pellets recovered through an 18- to 24-mesh sieve and a satisfactory 24-hour release curve. The kinetics of dissolution fit the Higuchi kinetics model. Stability tests of the drug pellets showed no notable changes in the rate of drug release, related substances (mean byproducts or impurities from interactions or decompositions), and drug content.

Original languageEnglish (US)
Pages (from-to)238-246
Number of pages9
JournalAdvances in Therapy
Volume21
Issue number4
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Drug Implants
Indapamide
Pharmaceutical Preparations
Germany
Research Personnel
Eudragit RS

Keywords

  • Coating
  • Eudragit RS100
  • Indapamide
  • Slow-release formulations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jia, W., Qiu, M., Sun, X., Qiu, Y., & Su, M. (2004). Preparation of indapamide slow-release pellets. Advances in Therapy, 21(4), 238-246.

Preparation of indapamide slow-release pellets. / Jia, Wei; Qiu, Mingfeng; Sun, Xia; Qiu, Yunping; Su, Mingming.

In: Advances in Therapy, Vol. 21, No. 4, 07.2004, p. 238-246.

Research output: Contribution to journalArticle

Jia, W, Qiu, M, Sun, X, Qiu, Y & Su, M 2004, 'Preparation of indapamide slow-release pellets', Advances in Therapy, vol. 21, no. 4, pp. 238-246.
Jia W, Qiu M, Sun X, Qiu Y, Su M. Preparation of indapamide slow-release pellets. Advances in Therapy. 2004 Jul;21(4):238-246.
Jia, Wei ; Qiu, Mingfeng ; Sun, Xia ; Qiu, Yunping ; Su, Mingming. / Preparation of indapamide slow-release pellets. In: Advances in Therapy. 2004 ; Vol. 21, No. 4. pp. 238-246.
@article{07a03cf3ee114e2cb6e6feae4d5d37db,
title = "Preparation of indapamide slow-release pellets",
abstract = "During the process of developing a slow-release formulation of indapamide, researchers created a drug-containing pellet coated with Eudragit{\circledR} RS100 (Rohm GMbH & Co. KG, Darmstadt, Germany) to control the rate at which the drug was released. The two main variables were the agglomerants used in the pellet preparation and the amount of Eudragit RS100 used to coat them. The optimal outcome was indicated by the greatest number of drug-containing pellets recovered through an 18- to 24-mesh sieve and a satisfactory 24-hour release curve. The kinetics of dissolution fit the Higuchi kinetics model. Stability tests of the drug pellets showed no notable changes in the rate of drug release, related substances (mean byproducts or impurities from interactions or decompositions), and drug content.",
keywords = "Coating, Eudragit RS100, Indapamide, Slow-release formulations",
author = "Wei Jia and Mingfeng Qiu and Xia Sun and Yunping Qiu and Mingming Su",
year = "2004",
month = "7",
language = "English (US)",
volume = "21",
pages = "238--246",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "4",

}

TY - JOUR

T1 - Preparation of indapamide slow-release pellets

AU - Jia, Wei

AU - Qiu, Mingfeng

AU - Sun, Xia

AU - Qiu, Yunping

AU - Su, Mingming

PY - 2004/7

Y1 - 2004/7

N2 - During the process of developing a slow-release formulation of indapamide, researchers created a drug-containing pellet coated with Eudragit® RS100 (Rohm GMbH & Co. KG, Darmstadt, Germany) to control the rate at which the drug was released. The two main variables were the agglomerants used in the pellet preparation and the amount of Eudragit RS100 used to coat them. The optimal outcome was indicated by the greatest number of drug-containing pellets recovered through an 18- to 24-mesh sieve and a satisfactory 24-hour release curve. The kinetics of dissolution fit the Higuchi kinetics model. Stability tests of the drug pellets showed no notable changes in the rate of drug release, related substances (mean byproducts or impurities from interactions or decompositions), and drug content.

AB - During the process of developing a slow-release formulation of indapamide, researchers created a drug-containing pellet coated with Eudragit® RS100 (Rohm GMbH & Co. KG, Darmstadt, Germany) to control the rate at which the drug was released. The two main variables were the agglomerants used in the pellet preparation and the amount of Eudragit RS100 used to coat them. The optimal outcome was indicated by the greatest number of drug-containing pellets recovered through an 18- to 24-mesh sieve and a satisfactory 24-hour release curve. The kinetics of dissolution fit the Higuchi kinetics model. Stability tests of the drug pellets showed no notable changes in the rate of drug release, related substances (mean byproducts or impurities from interactions or decompositions), and drug content.

KW - Coating

KW - Eudragit RS100

KW - Indapamide

KW - Slow-release formulations

UR - http://www.scopus.com/inward/record.url?scp=8744309957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8744309957&partnerID=8YFLogxK

M3 - Article

C2 - 15605618

AN - SCOPUS:8744309957

VL - 21

SP - 238

EP - 246

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 4

ER -